|
|
Blood, 1 November 2004, Vol. 104, No. 9, pp. 2722-2727.
Prepublished online as a Blood First Edition Paper on June 15, 2004; DOI 10.1182/blood-2004-02-0769.
 Previous Article | Next Article 
Submitted March 1, 2004
Accepted June 9, 2004
Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes
Aaron Tomer*
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
* Corresponding author; email: atomer{at}bgumail.bgu.ac.il.
Human megakaryocyte differentiation and maturation were studied in fresh marrow aspirates using multiparameter flow cytometric correlative analysis. The expression of glycoprotein (GP)IIb/IIIa, GPIIIa, GPIb and CD36 correlated directly with cell size and ploidy (r  0.97) however, GPIb acquisition was relatively slow. von Willebrand factor (vWF) is robustly expressed by early (2N and 4N) megakaryocytes, enabling their complete resolution from the other marrow cells at a level superior to that achieved with GPIIb/IIIa. Expression of myeloid CD45 and IgG-Fc RII (CDw32) increased with megakaryocyte maturation and contrasted with the declining expression of HLA-DR (negative in platelets). Interleukin-6 receptor expression in megakaryocytes was higher than in other marrow cells. Using the time-of-flight technique, the diameter of the megakaryocyte population was 37±4µm (mean±1SD) compared to 14±2µm for the total marrow cells, ranging from 21±4µm for 2N cells to 56±8µm for 64N cells. Cell size directly correlated with cell DNA (r=0.98). Receptor density of GPIIb/IIIa and GPIb decreased with the transition from 2N to 4N cells, then reached maximum at 32N-cells. We conclude that the present methods are useful for studying in vivo human megakaryocytopiesis in normal and altered states. The expression of vWF is a sensitive and distinctive marker for the identification of young marrow megakaryocytes.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. I. Fortoul, A. Gonzalez-Villalva, G. Pinon-Zarate, V. Rodriguez-Lara, L. F. Montano, and L. Saldivar-Osorio
Ultrastructural megakaryocyte modifications after vanadium inhalation in spleen and bone marrow
J. Electron Microsc. (Tokyo),
December 1, 2009;
58(6):
375 - 380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Takayama, H. Nishikii, J. Usui, H. Tsukui, A. Sawaguchi, T. Hiroyama, K. Eto, and H. Nakauchi
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
Blood,
June 1, 2008;
111(11):
5298 - 5306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Obaldia III
Clinico-Pathological Observations on the Pathogenesis of Severe Thrombocytopenia and Anemia Induced by Plasmodium vivax Infections During Antimalarial Drug Efficacy Trials in Aotus Monkeys
Am J Trop Med Hyg,
July 1, 2007;
77(1):
3 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Jacquelin, T. Kortulewski, P. Vaigot, A. Pawlik, G. Gruel, O. Alibert, P. Soularue, C. Joubert, X. Gidrol, and D. T.-L. Roux
Novel pathway for megakaryocyte production after in vivo conditional eradication of integrin {alpha}IIb-expressing cells
Blood,
September 15, 2005;
106(6):
1965 - 1974.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
